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Abstract
(-)-Oleocanthal (OC), a phenolic compound present in extra-virgin olive oil (EVOO), has been 
implicated in the health benefits associated with diets rich in EVOO. We investigated the effect of 
OC on human cancer cell lines in culture and found that OC induced cell death in all cancer cells 
examined as rapidly as 30 minutes after treatment in the absence of serum. OC treatment of non-
transformed cells suppressed their proliferation but did not cause cell death. OC induced both 
primary necrotic and apoptotic cell death via induction of lysosomal membrane permeabilization 
(LMP). We provide evidence that OC promotes LMP by inhibiting acid sphingomyelinase (ASM) 
activity, which destabilizes the interaction between proteins required for lysosomal membrane 
stability. The data presented here indicate that cancer cells, which tend to have fragile lysosomal 
membranes compared to non-cancerous cells, are susceptible to cell death induced by 
lysosomotropic agents. Therefore, targeting lysosomal membrane stability represents a novel 
approach for the induction of cancer-specific cell death.
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Introduction
Extra-virgin olive oil (EVOO), a central component of the Mediterranean diet, contains an 
abundance of phenolic antioxidants that are potent inhibitors of reactive oxygen species and 
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is associated with a reduced risk for several types of human cancer.1 Polyphenolic 
secoiridoids of EVOO have been shown to decrease viability of HER2-overexpressing 
breast cancer cells by selectively inducing apoptotic cell death.2 (-)-Oleocanthal (OC), a di-
aldehydic form of ligostride aglycone that has been isolated from EVOO, possesses a wide 
range of biological effects. Previous studies have reported its activity as a potent 
antioxidant; a non-steroidal anti-inflammatory agent that inhibits COX-1 and COX-2; a 
neuroprotectant that alters the structure and function of the neurotoxins β-amyloid and Tau, 
which are associated with the debilitating effects of Alzheimer disease; an inhibitor of 
proliferation, migration, and invasion of human breast and prostate cancer cells through c-
Met inhibition; an inhibitor of AMPK in colon cancer cells; and an inhibitor of macrophage 
inflammatory protein-1α in multiple myeloma.3-8
To investigate the anticancer effects of OC, we examined its effect on the viability and 
survival of cancerous and non-cancerous cells. Interestingly, OC rapidly (within 30 minutes) 
induced loss of viability in cancer cells in a dose-dependent manner. Under serum 
withdrawal, OC promoted primary necrotic cell death in cancer cells, which correlated with 
elevated levels of phosphorylated ERK1/2 in the absence of cleaved caspase-3 expression. 
In the presence of serum, a combination of apoptosis and secondary necrosis was observed. 
Importantly, OC induced a reversible cell cycle arrest in non-cancerous cells but did not 
affect their viability. Our findings indicate that OC-mediated cancer cell death is promoted 
by destabilization of the lysosomal membrane, leading to the induction of lysosomal 
membrane permeabilization (LMP). OC-induced LMP is mediated by the inhibition of acid 
sphingomyelinase (ASM) activity, which can be derepressed by upregulation of Hsp70 or 
dual treatment with anionic lipids. These data provide evidence that the anticancer benefits 
of EVOO result, in part, from the ability of OC to rupture lysosomal membranes in cancer 
cells leading to cell death via necrosis and/or apoptosis. Importantly, due to high lysosomal 
membrane integrety, non-cancerous cells remain viable.
Results
OC induces loss of cell viability in cancer cells but reversible cell cycle arrest in non-
cancerous cells
OC has previously been shown to inhibit proliferation, migration, and invasion of breast and 
prostate cancer cells via inhibition of c-Met phosphorylation.5 OC has also been reported to 
inhibit cell proliferation in multiple myeloma cells via induction of apoptosis and inhibition 
of macrophage inflammatory protein 1-α expression.7 To further explore the mechanism by 
which OC induces cell death in cancer cells, we investigated the effect of OC on cell 
viability in PC3 (prostate), MDA-MB-231 (breast), and BxPC3 (pancreatic) cancer cells. 
Under serum withdrawal, 20 μM OC rapidly induced a loss of cell adhesion within 30 min 
post treatment and resulted in 100% non-viability in all cancer cell lines after 24 h of 
treatment (Fig. 1A). Interestingly, OC increased the levels of phosphorylated p44/42 (also 
known as ERK1/ERK2), but did not significantly increase the levels of cleaved poly-ADP-
ribose polymerase (PARP), an indicator of apoptotic death, in the absence of serum. It was 
previously shown that ERK activation is a critical mediator of mitochondrial dysfunction 
and necrotic cell death of renal epithelial cells following treatment with oxidizing agents.9 
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Importantly, OC did not induce expression of cleaved caspase-3 in the absence of serum. 
Caspase-3, an effector caspase necessary for the morphological and biochemical features 
associated with apoptosis, is cleaved during both intrinsic and extrinsic apoptotic cell death 
pathways.10, 11 The absence of cleaved caspase-3 expression upon OC treatment in the 
absence of serum indicates that the cancer cells have bypassed the apoptotic machinery 
leading to cell death. In addition, OC treatment resulted in a complete loss of mitochondrial 
activity at low micromolar concentrations in the absence of serum, as measured by the MTT 
assay (data not shown). Taken together, the rapid loss of viability caused by OC, together 
with the absence of PARP and caspase-3 cleavage, suggests that OC induces primary 
necrotic cell death in the absence of serum in a wide range of cancer cells.
In the presence of serum, however, OC treatment increased the levels of cleaved PARP and 
cleaved caspase-3, which correlated with increased numbers of non-viable cells in all cancer 
cell lines examined (Fig. 1B). OC did not have a significant effect on the level of 
phosphorylated p44/42 in the presence of serum, when baseline levels of phosphorylated 
p44/42 tended to be high (Fig. 1B), and only partially inhibited mitochondrial activity (data 
not shown). Thus, in the presence of serum, OC induced cell death via activation of 
apoptotic mechanisms. Overall, these data indicate that OC rapidly induces robust cancer 
cell death via different mechanisms depending on whether serum is absent or present.
Targeted cancer therapies that are cytotoxic to tumors and non-toxic to non-cancerous 
tissues are in high demand but in short supply. Given that the data in Figs. 1A and 1B 
demonstrate that OC significantly induces cell death in cancer cells, we examined the effect 
of OC on non-cancerous BJ human fibroblasts, 3Y1 rat fibroblasts, and IMR90 human lung 
fibroblasts. As shown in Fig. 1C, OC inhibited cell proliferation in all 3 non-cancerous cell 
lines examined as determined by cell number after 72 h of treatment. Rapamycin was used 
as a positive control because of its ability to induce G1 cell cycle arrest.12 Importantly, OC 
did not induce PARP cleavage in the presence or absence of serum and cell proliferation was 
restored after 72 h of OC treatment in BJ cells (Fig. 1D, upper and lower left panel).
Phosphorylation of Rb is a critical step mediating progression through G1 to S phase of the 
cell cycle.13 Underphosphorylation of Rb inhibits E2F activity through sequestration, thus 
inhibiting cell cycle progression.14, 15 Rb phosphorylation at Ser608 is reported to be 
necessary for reduced binding affinity of E2F to Rb.16 We therefore examined the effect of 
OC on the levels of phospho-Rb at Ser608 in non-cancerous cells. As shown in Fig. 1D 
(right panel), treatment of non-cancerous BJ and 3Y1 cells with OC resulted in decreased 
levels of phospho-Rb at Ser608 after 24 h, which continued for 72 h in the presence of 
serum. IMR90 cells did not show a significant decrease in Rb phosphorylation at Ser 608, 
probably reflecting cell cycle arrest outside of G1.17 These data suggest that OC treatment 
does not induce cell death in non-cancerous cells but rather reversibly induces cell cycle 
arrest via suppression of Rb phosphorylation, which serves to protect healthy cells against 
the adverse effects of OC.
OC differentially induces cell death in cancer cells in the absence and presence of serum
The morphological and biochemical changes associated with apoptotic cell death occur 
between 6 and 12 h after a traumatic event that leads to apoptotic body formation between 
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24 and 48 h.18 The rapidity with which OC induces cell rounding and loss of substrate 
adherence in the absence of serum (observed within 30 min post treatment) suggests a non-
apoptotic form of cell death. As shown in Fig. 1A, 20 μM OC induced elevated ERK1/2 
phosphorylation, which has been associated with necrotic cell death,9 in the absence of 
cleaved PARP and cleaved caspase-3 expression. We therefore investigated the method by 
which OC induces cell death in the absence of serum using a cell death-specific assay kit 
that distinguishes apoptosis from necrosis. A lower concentration of OC (10 μM) was used 
for this assay to reduce the rate of cell rounding in order to determine the specific method of 
cell death. As shown in Fig. 2A, OC induced a significant number of necrotic cells after 24 h 
of treatment. The large number of necrotic cells observed explains the substantial decrease 
in cell viability in the absence of cleaved caspase-3 and limited increase in cleaved PARP 
(shown in Fig. 1A). Although PARP cleavage was not observed in the absence of serum due 
to activation of the primary necrotic cell death pathway, increased levels of cleaved PARP 
and caspase-3 were observed upon OC treatment in the presence of serum (Fig. 1B), which 
resulted in more apoptotic than necrotic cells (Fig. 2B). Signaling pathways that regulate cell 
death participate in both apoptosis and necrosis; thus, it is possible to have apoptotic and 
secondary necrotic cell death within the same cell population.19,20 Collectively, data in Figs. 
1 and 2 suggest that OC induces cell death in cancer cells via both apoptotic and necrotic 
mechanisms depending on the presence or absence of serum.
OC downregulates ASM activity to induce LMP and cell death in cancer cells that is 
reversed by anionic lipids
Primary necrosis caused by a severe insult, either extracellular or intracellular, can be 
identified by rapid permeabilization of the plasma membrane.19 Lysosomes have recently 
been implicated in cell death through the release of lysosomal hydrolytic enzymes into the 
cytosol, which leads to apoptosis (via mitochondrial outer membrane permeabilization 
[MOMP] and caspase activation) or necrosis (via cytosolic acidification).21 To determine 
whether LMP mediates OC-induced cancer cell death, we examined the integrity of the 
lysosomal membrane after OC treatment using acridine orange, a lysosomotropic 
metachromatic fluorochrome that emits a red fluorescence when in present at a high 
concentration within intact lysosomes.22 OC significantly reduced the red fluorescence in 
both the absence and presence of serum, indicating that OC-induced cell death is mediated 
by the induction of LMP in all cancer cell lines and conditions (Fig. 3A). However, OC did 
not reduce the red fluorescence in the absence or presence of serum in BJ cells, indicating 
that OC does not induce LMP in these non-cancerous cells (Fig. 3A lowest panel).
Lysosomal membrane integrity is regulated by the activity of ASM, a lysosomal lipase 
responsible for the hydrolysis of sphingomyelin (SM) to ceramide.23 Petersen et al. have 
shown that siramesine, a cationic amphiphilic drug, induces LMP as a result of inhibition of 
ASM activity.24 We therefore examined the effect of OC on the activity of ASM. As shown 
in Fig. 3B (left graph), under serum withdrawal conditions ASM activity was inhibited up to 
40% following treatment with 10 μM OC for 4 h. In the presence of serum, 10 μM OC 
induced a maximum 10% inhibition of ASM activity (Fig. 3B, right panel). The degree by 
which ASM activity is inhibited correlates with the specific cell death pathway that is 
activated upon OC treatment and the extent of LMP; massive or complete LMP rapidly 
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liberates proteases from the lysosomes and has been shown to induce necrotic cell death, 
whereas partial or selective LMP liberates proteases from the lysosome in a manner that 
activates programmed apoptotic cell death.25, 26 These findings reveal a correlation between 
OC-induced necrotic or apoptotic cell death and the level of ASM activity.
ASM activity is regulated by its ability to bind to bis (monoacylglycero)phosphate (BMP), 
an anionic lipid that is an essential co-factor for lysosomal sphingomyelin metabolism.27 
Hsp70 has been shown to bind with high affinity and specificity to BMP, thereby enhancing 
the stability of the BMP–ASM complex, which in turn inhibits LMP and promotes cell 
survival.23 Therefore, we examined whether Hsp70 inhibits OC-induced LMP. Cerulenin, a 
fatty acid synthase inhibitor, has been shown to upregulate Hsp70 expression through the 
ability of Hsp70 to interact directly with fatty acids.28 Under serum withdrawal conditions, 
cerulenin-mediated overexpression of Hsp70 partially inhibited OC-induced LMP in PC3 
cancer cells (Fig. 3C). Cationic lipids or cationic amphiphilic drugs have been shown to 
destabilize the lysosomal membrane by inhibiting the hydrolysis of SM via downregulation 
of ASM activity.24,29 However, anionic amphipathic lipids or free fatty acids have been 
shown to enhance ASM activity.30–32 We therefore examined the effect of an anionic lipid 
mixture on OC-induced LMP. As shown in Fig. 3D (left panel), treatment with anionic 
lipids inhibited OC-induced LMP in PC3 cells in the absence of serum. The inhibition of 
OC-induced LMP also correlated with an increase in cell viability as measured by the 
percentage of attached cells Fig. 3D (right panel). Dual treatment with lipids and OC did not 
result in cell death, as observed by the lack of floating cells after 24 to 72 h of OC treatment, 
although there was a decrease in cell proliferation. These data indicate that maintaining or 
enhancing ASM activity through the addition of anionic lipids increases the stability of the 
lysosomal membrane, thus preventing LMP-induced cell death in cancer cells. Collectively, 
the data in Figs. 1–3 indicate that OC inhibits ASM activity in cancer cells, leading to 
complete or partial LMP and resulting in necrotic or apoptotic cell death in the absence and 
presence of serum, respectively.
Discussion
The data presented here demonstrate that OC selectively induces cell death in cancer cells 
via downregulation of ASM activity leading to LMP, while reversibly arresting non-
cancerous cells. In non-cancerous cells, OC induces G1 cell cycle arrest via inhibition of Rb 
phosphorylation at Ser608, preventing cell cycle progression into S phase.33,34 Importantly, 
non-cancerous cells that are arrested by OC resume proliferation after 72 h of OC treatment.
In contrast to the cell cycle arrest observed in non-cancerous cells, cancer cells rapidly 
underwent either primary necrotic cell death under serum withdrawal conditions, correlating 
with increased ERK1/2 phosphorylation in the absence of cleaved caspase-3 and PARP, or 
caspase-3–dependent apoptotic cell death in the presence of serum via induction of LMP. 
During the development of cancer cells, lysosomes undergo morphological transformation 
that leads to increased size and greater cathepsin activity compared with those in normal 
cells.35 The increased lysosomal size renders cancer cells vulnerable to treatment with 
anticancer agents.36 LMP causes a release of cathepsins (lysosomal proteases) into the 
cytosol leading to degradation of cellular proteins.21 Accordingly, the amount and rate of 
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lysosomal enzyme release into the cytosol mediates the activation of necrotic or apoptotic 
signaling pathways.26 We have shown here that the degree of OC-mediated suppression of 
ASM activity correlates with activation of specific cell death pathways.
Although fragility of the lysosomal membrane increases the susceptibility of cancer cells to 
LMP, cells can overcome this vulnerability by overexpressing Hsp70, a regulator of 
multiprotein complex assembly and protein transport across cellular membranes.37 Hsp70 
localizes on the lysosomal membrane and protects against LMP by enhancing ASM activity 
and stabilizing the interaction between ASM and BMP.23,35 Therefore, overexpression of 
Hsp70 in cancer cells favors cell survival by increasing lysosomal integrity and preventing 
LMP.35,37 Increasing Hsp70 expression with cerulenin, a fatty acid synthesis inhibitor, 
suppresses OC-induced LMP in PC3 cells due to increased lysosomal membrane stability.28
Whereas cationic lipids destabilize the lysosomal membrane by regulating the interaction 
between ASM and the lysosomal membrane, anionic lipids such as BMP and 
phosphatidylinositol (PI) have been shown to activate ASM activity as measured by 
enhanced hydrolysis of SM.29,31,32 We have provided evidence that anionic free fatty acids 
are also capable of stabilizing the lysosomal membrane and preventing LMP. Our findings 
suggest that OC-mediated cancer cell death is due to its ability to act as a lysosomotropic 
agent and facilitate complete LMP in the absence of serum and partial LMP in the presence 
of serum, which is related to the rate of ASM activity inhibition.
Importantly, it was recently reported that OC prevents tumor growth in an orthotopic model 
of breast cancer in athymic nude mice.38 This study presented data implicating suppression 
of c-Met as a critical consequence of OC treatment although it was not clear whether LMP 
was involved in cell death or PARP cleavage was observed. Nonetheless, the study 
demonstrated that OC has similar effects in an animal model to those described in the 
current study with minimal effects on normal cells, thus reinforcing the potential of OC as a 
therapeutic agent in breast and other cancers.
Our study provides a mechanism by which OC selectively and rapidly induces cell death in 
cancer cells without being cytotoxic to non-cancerous cells. Compounds that induce 
lysosomal membrane destabilization, such as OC, represent a viable method to exploit the 
vulnerability of the enlarged lysosomes in cancer cells. Our data suggest that the 
chemopreventive activity of EVOO is due to the ability of its bioactive phenolic 
components, especially OC, to induce cell death by entering the lysosome and inhibiting 
ASM activity, which induces LMP. Therefore, the ability of OC to induce LMP in cancer 
cells, but not normal cells, represents a novel therapeutic strategy for treating a large number 
of cancer types in which lysosomes are enlarged and more sensitive to lysosomotropic 
agents.
Materials and methods
Cells and cell culture conditions
The BxPC3, PC3, MDA-MB-231, BJ, 3Y1, and IMR90 cells used in this study were 
obtained from the American Type Tissue Culture Collection and were maintained in 
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Roswell Park Memorial Institute Medium (RPMI) and Dulbecco's Modified Eagle Medium 
(DMEM), respectively, supplemented with 10% or 15% (IMR90) fetal bovine serum 
(Hyclone). No authentication was performed by the authors.
Materials
Rapamycin was obtained from LC Labs. (-)-OC, extracted from EVOO, was obtained from 
Dr. Alexios-Leandros Skaltsounis at the University of Athens Department of Pharmacology. 
The structure and purity (97%) of (-)-oleocanthal was determined by HPLC and 1H-NMR 
analysis. Acridine orange was obtained from Life Technologies. The Promokine Apoptotic/
Necrotic/Healthy cell detection kit and Cerulenin were obtained from Fisher Scientific. The 
Sphingomyelinase Fluorometric Assay kit was obtained from Cayman Chemicals. Primary 
antibodies specific for cleaved caspase-3, cleaved PARP, phospho-p44/42 (Thr202/Tyr204), 
total p44/42, β-actin, and phospho-Rb (Ser 608) were obtained from Cell Signaling 
Technology. Antibodies against glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and 
Hsp70 were obtained from Santa Cruz Biotechnology.
Lipid mix supplementation
Fatty acid mixture was obtained from Invitrogen (11905) and was supplied to cells as a 
1:200 dilution complexed with 5% fatty acid free bovine serum albumin (BSA; Sigma 
Aldrich) in a 2:1 ratio for a final lipid concentration in the media of 0.375 mg/L. The 
composition of the fatty acid mixture was arachidonic acid (20:4; 2 mg/L), cholesterol (220 
mg/L), DL-α-Tocophenol acetate (70 mg/L), linoleic acid (18:2; 10 mg/L), linolenic acid 
(18:3; 10 mg/L), myristic acid (14:0; 10 mg/L), oleic acid (18:1; 10 mg/L), palmitic acid 
(16:0; 10 mg/L), puronic F-68 (90,000 mg/L), stearic acid (18:0; 10 mg/L), Tween 80 (2,200 
mg/L).
Cell viability and proliferation, acid sphingomyelinase activity, apoptosis/necrosis cell 
assay
Cell viability was determined by the level of mitochondrial activity using the MTT (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay according to the vendor's 
instructions (Sigma Aldrich). Cell proliferation and percentage of non-viable cells were 
determined by calculating the percentage of attached cells compared to control as previously 
described.39 ASM activity was determined using the Sphingomyelinase Fluorometric Assay 
kit from Cayman Chemicals. Cell death was evaluated by 2 separate methods: examination 
of cleavage of the caspase-3 substrate PARP and detection of apoptotic, necrotic, and 
healthy cells by the Promokine Apoptotic/Necrotic/Healthy Cells Detection Kit following 
the manufacturer's guidelines. Briefly, by using a combination of Annexin V, ethidium 
homodimer III, and Hoechst 33342, apoptotic, necrotic, and healthy cells can be respectively 
quantified within the same cell population. Healthy cells are only stained by membrane 
permeable Hoechst 33342, with blue fluorescence. Apoptotic cells exhibit Annexin V green 
staining. Ethidium homodimer III, which is impermeant to live or apoptotic cells, stains 
necrotic cells intensely with red fluorescence. Cells entering late apoptosis (also known as 
secondary necrosis) are stained both green and blue.
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Immunofluorescence
Immunostaining for the cell death assay or lysosomal integrity was performed in a cell 
suspension. For the cell death assay, cells were incubated with FITC-Annexin V, ethidium 
Homodimer III, and Hoechst 33342, washed twice with a 1× Binding Buffer, and then 
resuspended in 30 μL 1× Binding Buffer. For the lysosomal integrity assay, cells were 
washed twice with PBS and then resuspended in 30 μL PBS. A 5-μL sample of the cell 
suspension was placed on a microscope slide and covered with a coverslip. Images were 
collected with an Olympus BX61 fluorescence microscope with a 10× objective, connected 
to a Hamamatsu ORCA-ER CCD camera and controlled by the SlideBook 5.1 image capture 
software.
Western blot analysis
Proteins were extracted from cultured cells in modified RIPA buffer (Upstate 
Biotechnology). Equal amounts of protein were separated by SDS-PAGE, transferred to 
nitrocellulose, and subjected to western blot analysis as described previously.40 Western 
blots were quantified using ImageJ software.
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OC -(-)Oleocanthal
PARP poly(ADP-ribose) polymerase
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Figure 1. 
OC induces loss of cell viability in cancer cells but reversible cell cycle arrest in non-
cancerous cells. (A, B) PC3, MDA-MB-231, and BxPC3 cells were plated at a density of 3 × 
105 cells/35-mm plate. After 24 h the medium was replaced with fresh medium containing 
0% serum (A) or 10% serum (B) and the indicated concentration of OC. After incubation for 
4 h, levels of cleaved PARP, phospho-p44/42 (Thr202/Tyr204), total p44/42, cleaved 
caspase 3, and GAPDH were determined. Cell viability was determined after 24 h of 
treatment. (C) BJ, 3Y1, and IMR90 cells were plated at a density of 5 × 104 cells/35-mm 
plate. After 24 h the cells were provided with fresh media containing 10% serum and the 
indicated concentration of OC or rapamycin (Rapa). After incubation for 24, 48, or 72 h the 
attached cells were counted to determine cell proliferation. (D) (Upper left panel) BJ cells 
were plated at a density of 2 × 105 cells/35-mm plate. After 24 h the cells were provided 
with fresh media containing 10% serum and the indicated concentration of OC. After 
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incubation for 4 h, levels of cleaved PARP, phospho-p44/42 (Thr202/Tyr204), and GAPDH 
were determined. (Lower left panel) BJ cells were plated at a density of 5 × 104 cells/35-mm 
plate. After 24 h the cells were provided with fresh media containing 10% serum and the 
indicated concentration of OC or Rapa. After a further 24, 48, 72, 96, or 120 h, the cells 
were counted to determine cell proliferation. (Right panel) BJ, 3Y1, and IMR90 cells were 
plated as above. After 24 h the cells were provided with fresh media containing 10% serum 
and the indicated concentration of OC or Rapa. After a further 24, 48, or 72 h, the cells were 
subjected to western blot analysis for phosphorylated Rb (Ser608) and GAPDH or β-actin. 
Error bars for all graphs represent the standard deviation from two independent experiments. 
All data shown are representative of at least two independent experiments.
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Figure 2. 
OC differentially induces cell death in cancer cells in the absence and presence of serum. 
(A) PC3, MDA-MB-231, and BxPC3 cells were plated at a density of 2 × 105 cells/60-mm 
plate. After 24 h the cells were provided with fresh media containing 0% serum and 10 μM 
OC as indicated. After a further 24 h the cells were subjected to the Apoptosis/Necrosis/
Healthy cell assay and analyzed by fluorescence microscopy using FITC, Texas Red, and 
DAPI filter settings. (B) PC3, MDA-MB-231, and BxPC3 cells were plated as above. After 
24 h the cells were provided with fresh media containing 10% serum and 10 μM OC as 
indicated. After a further 24 h, the cells were analyzed using the Apoptosis/Necrosis/Healthy 
cell assay kit as above. Cell numbers were determined using the ImageJ cell counter. Data 
shown are representative of at least two independent experiments. Scale bars = 200 μm.
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Figure 3. 
OC downregulates ASM activity to induce LMP and cell death in cancer cells that is 
reversed by anionic lipids. (A) PC3, MDA-MB-231, BxPC3, and BJ cells were plated at a 
density of 3 × 105 cells/60-mm plate. After 24 h the cells were provided with fresh media 
containing 0 or 10% serum and 10 μM OC as indicated. After a further 4 h the cells were 
treated with 5 μM acridine orange for 15 min and then subjected to fluorescence microscopy 
using a Texas Red filter setting. (B) PC3, MDA-MB-231, and BxPC3 cells were plated at a 
density of 5 × 106 cells/10-cm plate. After 24 h the cells were provided with fresh media 
containing 0 or 10% serum and 10 μM OC as indicated. Acid sphingomyelinase activity was 
measured after a further 4 h. (C) PC3 cells were plated at a density of 2 × 105 cells/60-mm 
plate. After 24 h the cells were provided with fresh media containing 10% serum and 30 μM 
cerulenin as indicated. After a further 24 h, the cells were provided with fresh media 
containing 0% serum and 10 μM OC as indicated and incubated for 4 h. The cells were 
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treated with 5 μM acridine orange for 15 min and subjected to fluorescence microscopy 
using a Texas Red filter setting or western blot analysis of Hsp70 and GAPDH. (D) PC3 
cells were plated at a density of 2 × 105 cells/60-mm plate. After 24 h the cells were 
provided with fresh media containing 0% serum, 10 μM OC, and lipids as indicated. After 4 
or 24 h the cells were treated with 5 μM acridine orange for 15 min and subjected to 
fluorescence microscopy using a Texas Red filter setting. Cell viability was determined after 
24 h. ImageJ software was used to quantify the western blots. Experiments shown are 
representative of at least two independent experiments. Scale bars = 200 μm.
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